Print Friendly and PDF
Previous month:
November 2017
Next month:
January 2018

December 2017

Top 10 articles for 2017 on this blog

On Tuesday, I wrote about the top stories for consumers for 2017. How depressing. With the Trump administration stomping all over consumer rights, it seems like there’s no end in sight for consumer gloom. Looking back on the top stories on my blog that readers liked during 2017 was much... Read more →

Top 14 consumer stories for 2017

This year, there hasn’t been very much good news for consumers. One of the few positive thing I can think of is that the Affordable Care Act hasn’t been repealed and replaced – yet. And, state governments are stepping up and filing lawsuits on behalf of consumers. Public interest and... Read more →

Ram pickups that can shift out of park prompts recall by Fiat Chrysler

Photo: Stratos L Fiat Chrysler Automobiles is recalling 1.8 million Ram pickups because the gear shifters can accidentally switch out of park. In certain "high-temperature conditions" the truck's shifter may be moved out of park when the driver isn't stepping on the brake, as would normally be required. This can... Read more →

Financial facts for Christmas and the New Year

Looking for the best places to celebrate Christmas and the New Year? Wondering what New Year’s resolutions to make? Pondering what to do about your finances? Worried about your credit card debt? Wallet Hub, a personal finance website, offers these articles to help you through the holidays and beyond: Chicago,... Read more →

Big Pharma pushes opioids, then works to squash DEA action to stop the epidemic and deaths

Did you see the “60 Minutes” stories or The Washington Post articles about Big Pharma putting profits over the public interest by pushing the sales of highly addictive opioids, including the distribution of these dangerous drugs irresponsibly to corrupt pharmacies and pill mills, and how the Drug Enforcement Agency was... Read more →

Drug company to pay $13.5 million for deceptive promotion of prescription drugs

Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $13.5 million to resolve charges it used deceptive marketing that promoted drug usage beyond what’s indicated on the labeling of four of its prescription drugs: Micardis, Aggrenox, Atrovent, and Combivent. The labeling means the prescribing information for health care providers. The settlement,... Read more →